| Symbol | EDNSF |
|---|---|
| Name | EDEN RESEARCH PLC. |
| Sector | UNDEFINED |
| Region | Europe |
| Industry | - |
| Address | OX14 4RQ United Kingdom 67c Innovation Drive Milton Park |
| Telephone | +44 1285 359555 |
| Fax | — |
| — | |
| Website | http://www.edenresearch.com |
| Incorporation | GB |
| Incorporated On | 1995 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | RSM UK Audit LLP;Pugh & Company, P.C.;Manning Elliott LLP;Manning Elliott LLP;KPMG LLP - New York, New York, (USA);Moody, Famiglietti, & Andronico;BDO USA, LLP;Davidson & Company LLP;Mao & Ying LLP;Deloitte & Touche LLP;CBIZ CPAs P.C.;KPMG Auditores Independentes;MNP LLP;Deloitte & Touche LLP;Smythe LLP.;MNP LLP;Prager Metis CPAs LLC;Goff Backa Alfera & Company, LLC;Fournier McDermott & Lamb;PKF Littlejohn;UHY LLP;Salberg & Company, P.A.;Marcum LLP;Saturna Group Chartered Professional Accountants LLP;Brent Crouch, CPA;WithumSmith + Brown PC;Weinberg & Company;Onestop Assurance PAC - (Singapore);KRP CPA;Anderson Tackman & Company;Mauldin & Jenkins, LLC;Ernst & Young LLP;Ernst & Young LLP;Nick Miseros;Ernst & Young LLP;Sadler, Gibb & Associates, LLC;KPMG LLP - New York, New York, (USA);PricewaterhouseCoopers LLP - Ottawa, Ontario (Canada);PricewaterhouseCoopers LLP;KPMG LLP - New York, New York, (USA);Integritat Audit, Accounting & Advisory, LLC;KPMG LLP.;CliftonLarsonAllen LLP;Davidson & Company LLP;PKF Littlejohn; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: LSE - London Stock Exchange |
| CIK | — |
| Description | Eden is the UKs only AIM listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Our vision is to be a global leader in sustainable crop protection through the development of bioactive products enabled or enhanced by our novel encapsulation and delivery technologies. Edens focus is on sustainably protecting high-value crops, improving crop yields and marketability. Our products, two of which are now commercially available, are based upon natural plant chemistry but deliver performance, ease of use, and cost on par with conventional alternatives. Eden has commercialised its first product, Mevalone®, a bio-fungicide, in 14 countries in Europe, the US, Australia and Kenya including the top 3 wine producing countries worldwide. Eden has partnered with Eastman Chemical for the commercialisation of its second product, CedrozTM, a nematicide, in 29 countries. Cedroz already has full approval in eleven countries, including the US, Spain, Italy and Mexico. Edens three EU-registered active ingredients, geraniol, eugenol and thymol, have all been approved for use in organic farming following inclusion in the EUs Organic Production Regulation. Edens Sustaine® microencapsulation technology, derived from yeast extract, is a viable alternatives to plastic forms of encapsulation. Additional info from OTC: |
No news found.